Skip to main content
Premium Trial:

Request an Annual Quote

Not Everyone Is Going to Freak Out

At his blog Epidemix, Thomas Goetz makes a case against California and New York’s cease-and-desist letters to personal genomics companies by saying that this will harm the public's health. He says that the small subset of individuals who might overreact to the tests is far outnumbered by those who will use the information wisely. Plus, adding a doctor to the mix would just drag things out, delaying people from getting the information they need to act early to prevent disease, he argues. "A fundamental principle of public health is awareness -- give citizens information earlier so that they can avoid putting themselves at risk."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.